Payer+Provider's Health System Review
16 drugmakers restricting 340B discounts
En Garde For SARS-CoV-2 Chimeras (Recombinants)
March 22, 2022
As a congressional stalemate stretches into its third week, officials warn it will hurt pandemic readiness.
Read the full post on Health